Category: Replacement Heart Valves
A Danish study presented at the American College of Cardiology's annual conference shows that transcatheter aortic valve implants are safe in low-risk patients.
(Reuters) — Transcatheter aortic valve implantation is safe for low-risk patients, according to a study presented at the American College of Cardiology meeting in San Diego.
Replacement heart valves made by Edwards Lifesciences and Medtronic once again dominate the American College of Cardiology's annual meeting, with long-term results for Edwards' Sapien and Medtronic's CoreValve complemented by even better data from their next-generation transcatheter aortic valve implants.
Transcatheter aortic valve implants once again took the spotlight at the annual meeting of the American College of Cardiology, with a spate of studies both confirming the long-term benefits of the replacement heart valves and showing that newer TAVI versions are even better.
St. Jude Medical can resume implantations of its Portico replacement heart valve after European authorities reinstated its CE Mark, the company tells MassDevice.com.
Cardiac Dimensions says it added $15 million to its coffers, taking the total raise from its latest funding round to $43 million as it readies a trial of its Carillon mitral valve implant.
Cardiac Dimensions today said it raised another $15.2 million for its Carillon mitral valve implant, taking the total of its most recent funding round to $43 million.
Medtronic's CoreValve transcatheter aortic valve implant delivered "substantial" benefits in a study of extreme-risk patients, but a significant minority died or had "very poor" quality of life after TAVI, according to a study in Journal of the American College of Cardiology.
CorMatrix Cardiovascular wins an investigational device exemption from the FDA for a small feasibility study of its new tricuspid valve replacement.
Georgia's CorMatrix Cardiovascular said this week that it plans to enroll up to 15 pediatric and adult patients in a feasibility study of its new tricuspid valve replacement device.
St. Jude Medical launches the Halo trial for its Master HP device, a 15mm mechanical heart valve for pediatric patients who need mitral valve replacement.
Masters HP Series 15mm
valve (l) and an adult valve.